Table 4.
Illustrative pathophysiologies of putative feedback failure inferred by disorderly secretory patternsa
Refs. | |
---|---|
I. Autonomous secretion | |
Somatotropinoma | 211,218 |
Corticotropinoma | 212,216,217,219 |
Prolactinoma | 214,230 |
Parathyroid adenoma | 43 |
Aldosteronoma | 213 |
Cortisol-secreting adrenal adenoma | 213 |
II. Secondary hypersecretory states | |
Hyperprolactinemia of stalk section | 230 |
Hyperaldosteronism of salt depletion | 43 |
Hyperparathyroidism in renal failure | 44 |
Hypergonadotropism: menopause | 304 |
Fasting-induced GH secretion | 211 |
III. Experimental feedback depletion (signal monitored) | |
↓ Te (LH secretion) | 109,239,340 |
↓ IGF-I (GH secretion) | 226 |
IV. Puberty | |
LH, GH: more disorderly despite ↑ Te and ↑ IGF-I | 323,324,328,329,334,367 |
V. Aging | |
LH, FSH, GH, ACTH | 74,81,217,305,327,367,368 |
IV. Prediabetes or diabetes mellitus type II | |
Insulin | 73 |
VII. Feedforward enhancement | |
↑ Orderliness of ACTH with low cortisol | 241 |
↑ Orderliness of PTH with low calcium | 226 |
VIII. Unexplained pathophysiology | |
PCOS ↓ orderliness of LH and Te | 338 |
Adult GH deficiency ↓ regularity | 326 |
Depression ↓ ACTH/cortisol orderliness | 369,370,371 |
Visceral obesity ↓ GH orderliness | 334 |
↓, Decreasing; ↑, increasing.
Defined quantitatively by elevated ApEn.